Insight Molecular Diagnostics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell IMDX and other ETFs, options, and stocks.About IMDX
Insight Molecular Diagnostics, Inc. is a molecular diagnostics company, which engages in the development and commercialization of diagnostic tests for the detection of cancer, including molecular diagnostic services to pharmaceutical customers. Its products include DetermaRx and DetermaIO.
IMDX Key Statistics
Stock Snapshot
With a market cap of 121.92M, Insight Molecular Diagnostics(IMDX) trades at $3.77. The stock has a price-to-earnings ratio of -2.32.
As of 2026-04-03, Insight Molecular Diagnostics(IMDX) stock has fluctuated between $3.02 and $3.79. The current price stands at $3.77, placing the stock +24.8% above today's low and -0.5% off the high.
The Insight Molecular Diagnostics(IMDX)'s current trading volume is 296.09K, compared to an average daily volume of 363.83K.
In the last year, Insight Molecular Diagnostics(IMDX) shares hit a 52-week high of $8.51 and a 52-week low of $2.33.
In the last year, Insight Molecular Diagnostics(IMDX) shares hit a 52-week high of $8.51 and a 52-week low of $2.33.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.